Paul B. Bolno's Insider Trades & SAST Disclosures
Paul B. Bolno's most recent trade in Wave Life Sciences Ltd. was a trade of 169,025 Ordinary Shares done at an average price of $2.5 . Disclosure was reported to the exchange on March 7, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Paul B. Bolno.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Wave Life Sciences Ltd. | Paul B. Bolno | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 07 Mar 2025 | 169,025 | 507,376 (1%) | 0% | 2.5 | 419,182 | Ordinary Shares |
| Wave Life Sciences Ltd. | Paul B. Bolno | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 9.57 per share. | 07 Mar 2025 | 169,025 | 338,351 (0%) | 0% | 9.6 | 1,617,569 | Ordinary Shares |
| Wave Life Sciences Ltd. | Paul B. Bolno | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 120,966 | 0 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd. | Paul B. Bolno | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 48,059 | 0 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd. | Paul B. Bolno | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 1,000,000 | 1,000,000 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd. | Paul B. Bolno | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 121,000 | 338,351 (0%) | 0% | 0 | Ordinary Shares | |
| Wave Life Sciences Ltd. | Bolno B. Paul | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2024 | 50,000 | 47,778 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd. | B. Paul Bolno | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 25 Nov 2024 | 50,000 | 217,351 (0%) | 0% | 15 | 750,000 | Ordinary Shares |
| Wave Life Sciences Ltd. | Bolno Paul B. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 25 Nov 2024 | 50,000 | 267,351 (0%) | 0% | 2.5 | 124,000 | Ordinary Shares |
| Wave Life Sciences Ltd. | Paul B. Bolno | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 14.32 per share. | 15 Nov 2024 | 51,234 | 217,351 (0%) | 0% | 14.3 | 733,671 | Ordinary Shares |
| Wave Life Sciences Ltd. | Paul B. Bolno | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 16 Oct 2024 | 90,474 | 268,585 (0%) | 0% | 15 | 1,357,110 | Ordinary Shares |
| Wave Life Sciences Ltd. | Paul B. Bolno | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.78 per share. | 21 Aug 2024 | 48,366 | 359,059 (1%) | 0% | 5.8 | 279,555 | Ordinary Shares |
| Wave Life Sciences Ltd. | Bolno B. Paul | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 1,008,600 | 1,008,600 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd. | Paul B. Bolno | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 771,000 | 771,000 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd. | Paul B. Bolno | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.04 per share. | 16 Feb 2023 | 29,400 | 407,425 (1%) | 0% | 4.0 | 118,776 | Ordinary Shares |
| Wave Life Sciences Ltd. | Paul B. Bolno | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 180,000 | 180,000 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd. | Paul B. Bolno | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2022 | 92,500 | 470,326 (1%) | 0% | 0 | Ordinary Shares | |
| Wave Life Sciences Ltd. | Paul B. Bolno | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.72 per share. | 04 May 2022 | 33,501 | 436,825 (1%) | 0% | 1.7 | 57,622 | Ordinary Shares |
| Wave Life Sciences Ltd. | Paul B. Bolno | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.32 per share. | 16 Feb 2022 | 33,150 | 377,826 (1%) | 0% | 2.3 | 76,908 | Ordinary Shares |
| Wave Life Sciences Ltd. | Paul B. Bolno | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 600,000 | 600,000 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd. | Paul B. Bolno | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 200,000 | 200,000 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd. | Paul B. Bolno | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 150,000 | 422,181 (1%) | 0% | 0 | Ordinary Shares | |
| Wave Life Sciences Ltd. | Paul B. Bolno | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 10.57 per share. | 01 Feb 2021 | 11,205 | 410,976 (1%) | 0% | 10.6 | 118,437 | Ordinary Shares |
| Wave Life Sciences Ltd. | Paul B. Bolno | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 15 Sep 2020 | 100,000 | 272,181 (0%) | 0% | 15 | 1,500,000 | Ordinary Shares |
| Wave Life Sciences Ltd. | Paul B. Bolno | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2020 | 100,000 | 97,778 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd. | Paul B. Bolno | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 15 Sep 2020 | 100,000 | 372,181 (1%) | 0% | 2.5 | 248,000 | Ordinary Shares |
| Wave Life Sciences Ltd. | Paul B. Bolno | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 12.00 per share. | 25 Aug 2020 | 25,000 | 272,181 (0%) | 0% | 12 | 300,000 | Ordinary Shares |
| Wave Life Sciences Ltd. | Paul B. Bolno | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2020 | 25,000 | 197,778 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd. | Paul B. Bolno | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 25 Aug 2020 | 25,000 | 297,181 (0%) | 0% | 2.5 | 62,000 | Ordinary Shares |
| Wave Life Sciences Ltd. | Paul B. Bolno | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jul 2020 | 100,000 | 222,778 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd. | Paul B. Bolno | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 02 Jul 2020 | 100,000 | 372,181 (1%) | 0% | 2.5 | 248,000 | Ordinary Shares |
| Wave Life Sciences Ltd. | Paul B. Bolno | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 10.27 per share. | 02 Jul 2020 | 95,921 | 272,181 (0%) | 0% | 10.3 | 985,109 | Ordinary Shares |
| Wave Life Sciences Ltd. | Paul B. Bolno | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 10.26 per share. | 02 Jul 2020 | 43,068 | 272,181 (0%) | 0% | 10.3 | 441,878 | Ordinary Shares |
| Wave Life Sciences Ltd. | Paul B. Bolno | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 10.82 per share. | 02 Jul 2020 | 4,509 | 315,249 (0%) | 0% | 10.8 | 48,787 | Ordinary Shares |
| Wave Life Sciences Ltd. | Paul B. Bolno | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 10.91 per share. | 02 Jul 2020 | 4,079 | 368,102 (1%) | 0% | 10.9 | 44,502 | Ordinary Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges